Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Javier Zúñiga-Varga"'
Autor:
Juan Pablo Rivas-de Noriega, Javier Andrés Galnares-Olalde, Javier Zúñiga-Varga, Juan Pablo Herrera-Félix, Marco Antonio Alegría-Loyola, Alonso Turrent-Carriles
Publikováno v:
Case Reports in Rheumatology, Vol 2018 (2018)
Introduction. Inflammatory myopathies are a rare group of diseases characterized by proximal weakness. Incidence ranges from 7.98/million/year and prevalence at 14/100,000. The utility of [18F] fluorodeoxyglucose (FDG) positron emission tomography (P
Externí odkaz:
https://doaj.org/article/c2599eeab4c5410188157cdc4b4223a9
Autor:
Luis Espinosa-Aguilar, Nadia A Gandarilla-Martínez, A Iván Smirnov-Castro, Braulia A Martínez-Díaz, Javier Zúñiga-Varga, Miguel A Collado-Ortiz
Publikováno v:
Neurología, Neurocirugía y Psiquiatría. 49:14-18
Autor:
Marco Antonio Alegría-Loyola, Javier Andrés Galnares-Olalde, Juan Pablo Herrera-Félix, Juan Pablo Rivas-de Noriega, Javier Zúñiga-Varga, Alonso Turrent-Carriles
Publikováno v:
Case Reports in Rheumatology, Vol 2018 (2018)
Case Reports in Rheumatology
Case Reports in Rheumatology
Introduction. Inflammatory myopathies are a rare group of diseases characterized by proximal weakness. Incidence ranges from 7.98/million/year and prevalence at 14/100,000. The utility of [18F] fluorodeoxyglucose (FDG) positron emission tomography (P
Publikováno v:
Reumatología Clínica. 7:37-40
ANCA-associated vasculitides are rare and complex systemic diseases. Collaborative studies in both Europe and the United States of America have been particularly important in the development of randomized clinical trials that have studied the safety
Publikováno v:
Reumatologia clinica. 7
ANCA-associated vasculitides are rare and complex systemic diseases. Collaborative studies in both Europe and the United States of America have been particularly important in the development of randomized clinical trials that have studied the safety
Autor:
Josefina, Alberú, Luis E, Morales-Buenrostro, Ricardo, Correa-Rotter, Teresa, Muñoz-Trejo, Javier, Zúñiga-Varga, Juan V, Cuéllar-González, Hector, Mayorga-Madrigal, Ramón, Vanegas-Carrero, Francisco, Aranda, Roxana, Rodríguez-Romo, Carlos, Herrera-Garcia, Luis, González-Michaca, Juan G, Sierra-Madero
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 60(5)
Preemptive therapy reduces the risk of cytomegalovirus disease in high-risk kidney transplant patients. The advantage of this strategy is that only a fraction of patients receive antiviral drugs for a limited time, which decreases costs and toxicity
Autor:
Rivas-de Noriega, Juan Pablo1, Galnares-Olalde, Javier Andrés1, Zúñiga-Varga, Javier2, Herrera-Félix, Juan Pablo2, Alegría-Loyola, Marco Antonio3, Turrent-Carriles, Alonso4
Publikováno v:
Case Reports in Rheumatology. 9/19/2018, p1-5. 5p.
Publikováno v:
Clinical & Translational Investigation / Revista de Investigación Clínica; 2011 Supplement, Vol. 63, p6-13, 8p
Autor:
Alberú, Josefina, Morales-Buenrostro, Luis E., Correa-Rotter, Ricardo, Muñoz-Trejo, Teresa, Zúñiga-Varga, Javier, Cuéllar-González, Juan V., Mayorga-Madrigal, Héctor, Vanegas-Carrero, Ramón, Aranda, Francisco, Rodríguez-Romo, Roxana, Herrera-García, Carlos, González-Michaca, Luis, Sierra-Madero, Juan G.
Publikováno v:
Clinical & Translational Investigation / Revista de Investigación Clínica; sep/oct2008, Vol. 60 Issue 5, p365-374, 10p